Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial
Yanjun Zhang, Gang Zeng, Hongxing Pan, Changgui Li, Biao Kan, Yaling Hu, Haiyan Mao, Qianqian Xin, Kai Chu, Weixiao Han, Zhen Chen, Rong Tang, Weidong Yin, Xin Chen, Xuejie Gong, Chuan Qin, Yuansheng Hu, Xiaoyong Liu, Guoliang Cui, Congbing Jiang, Hengming Zhang, Jingxin Li, Minnan Yang, Xiaojuan Lian, Yan Song, Jinxing Lu, Xiangxi Wang, Miao Xu, Qiang Gao, Fengcai Zhu
doi: https://doi.org/10.1101/2020.07.31.20161216
